{"denomUnitsSelected":"Participants","description":"The time to patient toxicity of drug combination bortezomib with arsenic trioxide, ascorbic acid and high-dose melphalan defined in days from baseline measure to occurence of adverse events grade 4 (life threatening or disabling) according to National Cancer Institute Common Toxicity Criteria (CTC), version 3.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to event occurence (assessed weekly first 30 days)","title":"Time to Toxicity","type":"SECONDARY"}